SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914248-02-000037
Filing Date
2002-02-13
Accepted
2002-02-13 00:00:00
Documents
1
Group Members
AUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSEMG ADVISERS LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.PSPECIAL SITUATIONS FUND III, L.P.SPECIAL SITUATIONS PRIVATE EQUITY FUND, L.P

Document Format Files

Seq Description Document Type Size
1 intl13gt.txt SC 13G 17196
  Complete submission text file 0000914248-02-000037.txt   19527
Mailing Address 153 EAST 53RD STREET 51ST FLOOR NEW YORK NY 10022
Business Address 153 E 53 ST 51ST FL NEW YORK NY 10022 2128325300
SPECIAL SITUATIONS FUND III L P (Filed by) CIK: 0000914248 (see all company filings)

IRS No.: 133737427 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-07
INTERLEUKIN GENETICS INC (Subject) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-53249 | Film No.: 02541565
SIC: 2835 In Vitro & In Vivo Diagnostic Substances